BEAM BEAM THERAPEUTICS INC Management Changes 8-K Filing 2024 - Board Expansion Beam Therapeutics Inc. expanded its Board of Directors from seven to eight members by electing Chirfi Guindo as a Class I director, effective December 2, 2024, with a term expiring at the 2027 annual meeting.Get access to all SEC 8-K filings of the BEAM THERAPEUTICS INC